Author

R. H. Thompson

Observed names: R. Thompson, R.H. Thompson, RH Thompson

Observed institutions: Fox Chase Cancer Center, Cleveland Clinic, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Spectrum Health, MetroHealth Medical Center, Glickman Urological Institute, Michigan State University

OpenAlex ID: A5111640917

Immunotherapy in Prostate Cancer

2015 · Ilya Sobol, R. H. Thompson, et al. · Current Urology Reports · 13

Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort

2011 · SP Kim, ND Shah, et al. · International braz j urol · 12

Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma

2008 · R. H. Thompson, X. Zang, et al. · Journal of Clinical Oncology · 3

Lymph node dissection is not associated with increased 30-day complications among patients undergoing radical nephrectomy for renal cell carcinoma: A propensity-score based analysis

2017 · B. Gershman, D. Moreira, et al. · European Urology Supplements · 1

Use of comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys to investigate the role of nonmodifiable factors in determining ultimate renal function.

2011 · B. R. Lane, P. Russo, et al. · Journal of Clinical Oncology · 1

Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis (VTT) of renal vein branches: Retrospective, multi-center analysis of perioperative, functional, and oncologic outcomes

2017 · F. Zattoni, R. Thompson, et al. · European Urology Supplements

Predictors and outcomes for late recurrence of renal cell carcinoma.

2011 · S. P. Kim, C. J. Weight, et al. · Journal of Clinical Oncology

Works count: 7

Citation count: 30

H-index: 3

I10-index: 2